Stay updated on RP2 Monotherapy and RP2 with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the RP2 Monotherapy and RP2 with Nivolumab Clinical Trial page.

Latest updates to the RP2 Monotherapy and RP2 with Nivolumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new Revision: v3.4.2 entry was added, and the old funding-lapse notice and Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check21 days agoChange DetectedAdded a notice about potential delays due to a lapse in government funding and updated site status. The page revision was updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.7%

- Check28 days agoChange DetectedAdded a glossary option and a color-coded change legend (green for additions, red for deletions). Updated the revision notice from v3.3.4 to v3.4.0 and adjusted the No FEAR Act data wording.SummaryDifference0.9%

- Check42 days agoChange DetectedThe study history now lists a new Revision: v3.3.4 as the most recent version, replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe history page adds a Revision: v3.3.3 entry and removes the HHS Vulnerability Disclosure link in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedA new revision entry, v3.3.2, was added to the study record history, replacing v3.3.1.SummaryDifference0.1%

Stay in the know with updates to RP2 Monotherapy and RP2 with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RP2 Monotherapy and RP2 with Nivolumab Clinical Trial page.